… associated visual field loss for which elevated intraocular pressure is one of the primary risk
… [17] Salbutamol is a β 2 -specific adrenergic agonist used as an inhalant for bronchodilation …

… This study aimed to determine the reported risk of glaucoma, ocular hypertension (OHT) …
that assess ocular outcomes related to glaucoma in ICS and INS users. Study selection, risk of …

… the ocular instillation of either betaxolol hydrochloride 1% (Alcon Laboratories, Fort Worth,
TX) or normal saline, 1 drop per eye in a … In 5 of these subjects, inhaled bronchodilator was ad…

… to administer inhaled bronchodilators to patients bronchodilators … It is our clinical sprayed
directly into the eye, and particular … The potential risks of cardiac side effects of There is no …

… A mouthpiece may avoid the risk of ocular complication with anticholinergic agents. … 7)
Value (and possible risks) of nebulized bronchodilator therapy in chronically hypoxaemic patients …

… 1.2 In addition, treatment with inhaled corticosteroids has been shown to reduce the risk of
… bronchial asthma, which was treated with inhaled albuterol. He was a glaucoma suspect on …

… We compared the risk of events between patients newly prescribed inhaled long-acting β-agonists
and anticholinergics, after matching and adjusting for prognostic factors. …

… In cases where the medical history necessitates the continuation of bronchodilators (for
example… to study current nebulization practice and intent to avoid additional risks by introducing a …

… in hospitalized patients receiving continuing nebulized therapy. A 66-… successful treatment
with nebulized albuterol sulfate and ipratropium … Ocular hazards of nebulized bronchodilators …

… inflammation with inhaled long-acting bronchodilators. Future … of inhaled long-acting
bronchodilators, in which the risk … that the use of inhaled long-acting bronchodilators in COPD …